{"id":11110,"date":"2023-03-22T00:00:00","date_gmt":"2023-03-22T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/"},"modified":"2025-08-19T08:28:12","modified_gmt":"2025-08-19T13:28:12","slug":"avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/","title":{"rendered":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL)"},"content":{"rendered":"<p>La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.<sup>2&nbsp;&nbsp;<\/sup>Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs tissus, y compris la peau, la bouche, les yeux, les articulations, le foie, les poumons, l&rsquo;\u0153sophage et le tractus gastro-intestinal.<\/p>\n<p><a class=\"ButtonSimple\" href=\"https:\/\/sanoficanada.fr.mediaroom.com\/2023-03-21-Avis-de-conformite-emis-concernant-Rezurock-MC-comprimes-de-belumosudil\" target=\"_blank\" rel=\"noopener\">Lire la suite ici<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2&nbsp;&nbsp;Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11110","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11110"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11110\/revisions"}],"predecessor-version":[{"id":31266,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11110\/revisions\/31266"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}